Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Most outcomes were similar in lean and heavy people with fatty liver disease, but the lean group had higher liver-related mortality.
Advocates are working to deliver medication directly to patients to combat this alarming decrease in care.
People treated with direct-acting antivirals had a lower risk for liver failure and liver cancer as well as much lower mortality.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Even though as many as 97% of patients can be cured with medication, many still don’t receive the treatment.
Fewer people have registered for liver transplants and hepatitis C deaths have been drastically reduced.
Another study found that children with fatty liver disease are at high risk for diabetes.
People who achieved SVR two or more years ago were less likely to develop hepatocellular carcinoma than those cured more recently.
The antiviral treatment is safe and effective for pediatric patients ages 12 and up.
People with hepatocellular carcinoma had improved survival after the advent of direct-acting antiviral therapy.
However, people with liver cirrhosis remain at risk and should continue screening even after being cured.
Over the past decade, deaths related to HBV rose significantly in West Virginia and Kentucky.
People under 50 are increasingly likely to develop cancers of the breast, colon, liver and more.
Many people living with hepatitis B and C don’t know it.
Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.
Excess cholesterol can cause liver scarring and inflammation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.